‘Targeted’ molecular diversity: design and development of non-peptide antagonists for cholecystokinin and tachykinin receptors

This publication has 9 references indexed in Scilit:

• The development of a novel series of non-peptide tachykinin NK3 receptor selective antagonists
  Bioorganic & Medicinal Chemistry Letters, 1995
• The rational development of small molecule tachykinin NK3 receptor selective antagonists - the utilisation of a dipeptide chemical library in drug design
  Bioorganic & Medicinal Chemistry Letters, 1994
• Cholecystokinin type B receptor antagonist PD-136,450 is a partial secretory agonist in the stomach and a full agonist in the pancreas of the rat.
  Gut, 1994
• PD 135158, a CCKB/ggastrin receptor antagonist, stimulates rat pancreatic enzyme secretion as a CCKA receptor agonist
  European Journal of Pharmacology, 1993
• The design of a dipeptide library for screening at peptide receptor sites
  Bioorganic & Medicinal Chemistry Letters, 1993
• Cholecystokinin dipeptoid antagonists: design, synthesis, and anxiolytic profile of some novel CCK-A and CCK-B selective and mixed CCK-A/CCK-B antagonists
  Journal of Medicinal Chemistry, 1993
• The effect of CCK_B/gastrin antagonists on stimulated gastric acid secretion in the anaesthetized rat
  British Journal of Pharmacology, 1991
• Minimum analogue peptide sets (MAPS) for quantitative structure‐activity relationships
  International Journal of Peptide and Protein Research, 1991
• Cholecystokinin Antagonists
  Annual Review of Pharmacology and Toxicology, 1991